Written by Keen Meds  ·  Reviewed by Licensed Clinical Providers  ·  March 1, 2026

Key Insight: Average testosterone declines at 1-2% per year after age 30. By age 70, average testosterone is 35% lower than peak levels -- with 20-30% of men over 60 meeting clinical criteria for hypogonadism.

> Average testosterone declines at 1-2% per year after age 30. By age 70, average testosterone is 35% lower than peak levels -- with 20-30% of men over 60 meeting clinical criteria for hypogonadism.

Medically reviewed by licensed clinical providers · March 2026

Testosterone does not fall off a cliff at a single age. It declines gradually, beginning in a man's early 30s, and the cumulative effect over decades is substantial. By the time most men notice symptoms -- reduced energy, changes in body composition, declining libido, or mood shifts -- the decline has typically been underway for years. Understanding what happens hormonally at each decade, how to interpret lab values in context, and what factors accelerate or slow the process gives men a clearer framework for making informed decisions about monitoring and treatment.

The Biology Behind Age-Related Testosterone Decline

Testosterone production is governed by the hypothalamic-pituitary-gonadal (HPG) axis -- a three-layer signaling system. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses. This signals the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH, in turn, signals Leydig cells in the testes to produce testosterone.

Aging disrupts this axis at multiple levels simultaneously. Hypothalamic GnRH pulse frequency and amplitude decline with age, reducing the upstream signal. Pituitary responsiveness to GnRH diminishes. And Leydig cell number and function in the testes decrease over time -- the testicular machinery produces less testosterone even when adequately signaled.

The result is a slow, systemic decline that is not driven by a single point of failure. This is clinically important because it means testosterone decline in older men is not simply a matter of "low signal from above" (secondary hypogonadism) -- it often has a primary component as well. This distinction matters when evaluating treatment options and interpreting LH and FSH levels on a lab panel.

Decade by Decade: What the Numbers Look Like

The 30s. Testosterone typically peaks in the late teens to mid-20s and begins its decline in the early 30s. The 1 to 2% annual rate of decline during this decade is usually not yet symptomatic -- most men are starting from a high enough baseline (often 600 to 900 ng/dL or above) that a few percentage points of annual loss has minimal functional impact. This decade is the baseline-establishment period.

The 40s. By the mid-to-late 40s, cumulative decline of 10 to 20% from peak may be apparent. Total testosterone levels for many men in their late 40s fall in the 400 to 550 ng/dL range. Some men remain well above 600 ng/dL; others have already crossed below 400 ng/dL. This is also the decade when SHBG (sex hormone-binding globulin) begins rising more meaningfully, which reduces the fraction of testosterone that is biologically available. A total testosterone reading that looks "acceptable" in the 40s may correspond to a meaningfully lower free testosterone level than the same number would have in the 30s.

The 50s. The 50s often mark the decade when men first become symptomatic at scale. Research suggests that 15 to 25% of men in their 50s have total testosterone below 300 ng/dL -- the threshold the Endocrine Society uses to define clinical hypogonadism. Symptom burden commonly includes fatigue, reduced lean muscle mass, increased abdominal adiposity, declining libido, and mood changes. This is also the decade when many men have the first conversations with a physician about their hormone levels.

The 60s and beyond. By age 60, average testosterone has fallen 20 to 30% from peak values. By age 70, average levels are approximately 35% below peak. Between 20 and 30% of men over 60 meet clinical criteria for hypogonadism. This is also the population most studied in major TRT trials -- including the T Trials (NEJM 2016) and TRAVERSE (NEJM 2023, Lincoff et al.), which enrolled 5,246 men with an average age of 66.

Free Testosterone, SHBG, and Why the Full Picture Matters

Total testosterone is the standard starting measurement, but it does not tell the complete story. Approximately 44 to 65% of circulating testosterone is tightly bound to SHBG, and an additional 30 to 40% is loosely bound to albumin. Only the SHBG-unbound fraction -- free testosterone (about 2 to 3% of total) plus albumin-bound -- is considered bioavailable.

SHBG increases with age. This is clinically significant because a man with a total testosterone of 380 ng/dL at age 55 may have a substantially lower free testosterone than a man of 30 with the same total level. The Endocrine Society guidelines recommend measuring free testosterone when total testosterone is borderline and symptoms are present, precisely because the total number can underestimate functional deficiency in older men.

This is also why the simple "normal range" on a lab report -- often cited as 300 to 1000 ng/dL across all ages -- can be misleading. A 65-year-old man at 320 ng/dL may be clinically low relative to his own prior baseline and his SHBG-adjusted free testosterone, even though 320 is technically within the broad reference range.

Lifestyle Factors That Accelerate or Slow Decline

The 1 to 2% annual average is exactly that -- an average. Individual trajectories vary considerably. Factors consistently associated with accelerated testosterone decline include:

Obesity. Adipose tissue converts testosterone to estradiol via aromatase. Higher body fat -- particularly visceral abdominal fat -- is associated with lower testosterone levels. The relationship is bidirectional: low testosterone promotes fat accumulation, which further reduces testosterone.

Chronic sleep disruption. The majority of daily testosterone production occurs during sleep. Men averaging fewer than 5 hours per night show significantly lower testosterone than those averaging 7 to 8 hours. Sleep apnea, common after 40, independently suppresses testosterone output.

Sedentary behavior. Regular resistance training is associated with higher testosterone levels. Men who maintain muscle-building physical activity tend to decline more slowly than those who are sedentary.

Chronic alcohol use and metabolic disease. Both are associated with impaired Leydig cell function and accelerated hormonal decline.

Conversely, maintaining healthy body weight, quality sleep, regular resistance exercise, and metabolic health are associated with a slower rate of age-related decline -- though they cannot fully prevent the underlying HPG axis changes.

What Numbers Actually Matter Clinically

The Endocrine Society's clinical practice guidelines define hypogonadism as total testosterone below 300 ng/dL on two separate morning fasting measurements, accompanied by symptoms. Both components -- the lab result and the symptom burden -- are required for a clinical diagnosis. A low number without symptoms, or symptoms without a confirmed low number, does not meet the threshold for initiating TRT under current guidelines.

For men with total testosterone between 300 and 400 ng/dL, free testosterone measurement provides important additional context. Symptom burden and clinical judgment guide treatment decisions in this range.

The treatment target for TRT is generally 400 to 700 ng/dL -- mid-physiological range -- not the upper end of the reference interval. This is relevant to the delivery method and dosing approach used.

Frequently Asked Questions

Can a man in his 40s have testosterone low enough to qualify for treatment?

Yes. While clinical hypogonadism (below 300 ng/dL on two fasting morning tests plus symptoms) is more prevalent in men over 50, it does occur in men in their 30s and 40s. Age is not a criterion for diagnosis -- confirmed hormonal deficiency combined with symptoms is. Men in their 40s who are symptomatic should pursue lab evaluation rather than attributing changes solely to "normal aging."

Does testosterone decline cause all the symptoms, or is some of it just getting older?

Both factors contribute and they often overlap. Some changes -- reduced recovery time, mild energy decline -- are partly attributable to non-hormonal aging processes. However, the symptom cluster associated with hypogonadism (fatigue, low libido, mood changes, loss of lean mass, increased body fat, reduced motivation) does track closely with testosterone levels in clinical research, and improving testosterone to mid-physiological range is associated with symptom improvement in men with confirmed deficiency.

Should men monitor testosterone levels even if they feel fine?

Clinical guidelines do not currently recommend population-level testosterone screening in asymptomatic men. However, men with symptoms, metabolic risk factors (obesity, type 2 diabetes, sleep apnea), or a family history of hypogonadism have a reasonable basis for discussing baseline labs with their physician. Having a baseline from the 30s or 40s provides useful clinical context if symptoms emerge later.

Is Age-Related Testosterone Decline Affecting How You Feel?

If fatigue, reduced libido, body composition changes, or mood shifts have become a pattern, declining testosterone may be a contributing factor. A blood test is the only way to confirm.

Keen Meds connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, you receive a prescription for Testosterone Spray Rx -- delivered via Hypospray®, Keen's needle-free transdermal spray platform.

Start your Keen Testosterone Spray Program →

Medically reviewed by Licensed Clinical Providers · March 2026

Related reading: